Indirect risks of complementary and alternative medicine: Promises and problems

Palgrave Macmillan
Publication Type:
Traditional, Complementary and Integrative Medicine, 2012, 1st, pp. 212 - 219
Issue Date:
Full metadata record
Files in This Item:
Filename Description Size
Thumbnail2011005957OK.pdf1.36 MB
Adobe PDF
A discussion of issues of safety and risk around complementary and alternative medicine (CAM) has primarily revolved around issues of direct risk, including adverse events (such as the potential hepatotoxicity of CAM products or potential CAM-drug interactions) and the monitoring of these events (pharmacovigilance). Yet the development of a broader public health agenda for CAM (Adams, 2008) provides an opportunity for a new focus on the inherent indirect health risks associated with these medicines - representing a novel, innovative approach to the consideration of risk and safety in CAM.
Please use this identifier to cite or link to this item: